NDC Product Labeler Catalent Indiana, Llc

Catalent Indiana, Llc labeler's code is 61434. The labeler has 28 products that have an assigned National Drug Code.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Product Type Status
61434-002 Durvalumab Injection, SolutionInjection, SolutionHuman Prescription DrugUNFINISHED
61434-002 Durvalumab Injection, SolutionInjection, SolutionHuman Prescription DrugUNFINISHED
61434-003 EteplirsenInjectionHuman Prescription DrugUNFINISHED
61434-007 AfliberceptInjection, SolutionHuman Prescription DrugUNFINISHED
61434-011 DiluentSolutionHuman Prescription DrugUNFINISHED
61434-020 AdalimumabInjection, SolutionDrug For Further ProcessingUNFINISHED
61434-021 CemiplimabInjectionHuman Prescription DrugUNFINISHED
61434-024 Rhuph20InjectionBulk IngredientUNFINISHED
61434-035 EteplirsenInjectionHuman Prescription DrugUNFINISHED
61434-038 DurvalumabInjection, SolutionHuman Prescription DrugUNFINISHED
61434-040 EpinephrineInjectionHuman Prescription DrugUNFINISHED
61434-041 EpinephrineInjectionHuman Prescription DrugUNFINISHED
61434-052 Atoltivimab, Maftivimab, And OdesivimabInjection, SolutionHuman Prescription DrugUNFINISHED
61434-062 AfliberceptInjection, SolutionHuman Prescription DrugUNFINISHED
61434-063 PozelimabInjection, SolutionHuman Prescription DrugUNFINISHED
61434-064 OdronextamabInjection, SolutionDrug For Further ProcessingUNFINISHED
61434-066 BenralizumabInjection, SolutionHuman Prescription DrugUNFINISHED
61434-067 SemaglutideInjection, SolutionHuman Prescription DrugUNFINISHED
61434-068 SemaglutideInjection, SolutionHuman Prescription DrugUNFINISHED
61434-069 Imetelstat SodiumInjection, Powder, Lyophilized, For SolutionHuman Prescription DrugUNFINISHED
61434-070 Ansuvimab-zyklInjectionDrug For Further ProcessingUNFINISHED
61434-071 Ansuvimab-zyklInjection, Powder, Lyophilized, For SolutionHuman Prescription DrugUNFINISHED
61434-072 OdronextamabInjection, SolutionDrug For Further ProcessingUNFINISHED
61434-073 AfliberceptInjection, SolutionDrug For Further ProcessingUNFINISHED
61434-074 AfliberceptInjection, SolutionDrug For Further ProcessingUNFINISHED
61434-075 NivolumabInjection, SolutionDrug For Further ProcessingUNFINISHED
61434-076 RavulizumabInjection, SolutionDrug For Further ProcessingUNFINISHED
61434-077 AfliberceptInjection, SolutionDrug For Further ProcessingUNFINISHED